4//SEC Filing
Adams Kendra 4
Accession 0001662579-24-000014
CIK 0001662579other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:02 PM ET
Size
8.8 KB
Accession
0001662579-24-000014
Insider Transaction Report
Form 4
Adams Kendra
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-02-13$6.53/sh−1,301$8,496→ 45,339 total - Award
Common Stock
2024-02-14+36,700→ 82,039 total - Award
Stock Option (Right to Buy)
2024-02-14+165,300→ 165,300 totalExercise: $7.31Exp: 2034-02-13→ Common Stock (165,300 underlying)
Footnotes (3)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.
- [F2]Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025.
- [F3]The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001991929
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:02 PM ET
- Size
- 8.8 KB